candeblo 2 mg - tabletten
g.l. pharma gmbh - candesartan cilexetil -
candeblo 32 mg - tabletten
g.l. pharma gmbh - candesartan cilexetil -
candeblo 4 mg - tabletten
g.l. pharma gmbh - candesartan cilexetil -
candeblo 8 mg - tabletten
g.l. pharma gmbh - candesartan cilexetil -
candeblo amlo 8 mg/5 mg-tabletten
g.l. pharma gmbh - amlodipin besilat; candesartan cilexetil -
candeblo amlo plus hct 16 mg/10 mg/12,5 mg hartkapseln
g.l. pharma gmbh - amlodipin besilat; candesartan cilexetil; hydrochlorothiazid -
debridat 100 mg
farmea - franta - trimebutinum - compr. film. - 100mg - med. pt.tulburari intestinale functionale anticolinergice de sinteza, esteri cu grup aminotertiar
debridat 200 mg
farmea - franta - trimebutinum - compr. film. - 200mg - med. pt.trat.tulburarilor functionale gastro-intestinale anticholinergice sintetice esteri cu grup tertiar amino
debridat 24 mg/5 ml
farmea - franta - trimebutinum - gran. pt. susp. orala - 24mg/5ml - med. pt.tulburari intestinale functionale anticolinergice de sinteza, esteri cu grup aminotertiar
raxone
chiesi farmaceutici s.p.a - idebenone - optic atrophy, hereditary, leber - other psychostimulants and nootropics, psychoanaleptics, - raxone is indicated for the treatment of visual impairment in adolescent and adult patients with leber’s hereditary optic neuropathy (lhon).